Experience of using сrizotinib in patients with ALKpositive non-small cell lung cancer by E. V. Reutova, L. V. Laktionova, D. T. Marinov, D. A. Peregudov, T. N. Borisova

Get full text

Phenotypic transformation as a cause of secondary drug resistance to osimetinib clinical observation by L. A. Nelyubina, E. V. Reutova, K. K. Laktionov, D. I. Yudin, D. T. Marinov, E. N. Kozak, V. V. Mochalnikova

Get full text

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION by К. К. LAKTIONOV, М. V. PEREGUDOVA, V. V. BREDER, E. V. REUTOVA, D. A. PEREGUDOV, M. S. ARDZINBA, P. A. CHERNENKO, D. T. MARINOV

Get full text

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation by K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba

Get full text

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer by D. I. Yudin, K. K. Laktionov, D. T. Marinov, V. V. Breder, A. K. Allakhverdiev, T. N. Borisova, A. H. Bekyashev, K. P. Laktionov, V. A. Aleshin, M. S. Ardzinba

Get full text

Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer by T. N. Borisova, A. V. Nazarenko, K. K. Laktionov, S. I. Tkachev, S. B. Alieva, V. V. Breder, O. P. Trofimova, V. V. Glebovskaya, A. A. Fedorova, D. T. Marinov, N. A. Meshcheriakova, S. M. Ivanov, S. G. Gerasimov

Get full text